Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
LaCasce, Ann S. , Bociek, R. Gregory , Sawas, Ahmed , Caimi, Paolo, Agura, Edward, Matous, Jeffrey, Ansell, Stephen M. , Crosswell, Howland E. , Islas‐Ohlmayer, Miguel, Behler, Caroline, Cheung, Eric, Forero‐Torres, Andres , O’Connor, Owen A. , Josephson, Neil C. , Advani, Ranjana H. , Advani, Ranjana H , Vose, Julie M. , Wang, Yinghui

Mayo Clinic

Blood | April 27, 2018 | Volume: 132 | Issue: 1 | Pages: 40-48

10.1182/blood-2017-11-815183 | PMID 29703778 Get It

Key PointsThe outpatient BV and bendamustine regimen is highly active as first salvage therapy in relapsed/refractory HL, with manageable toxicity. The CR rate of 73.6% exceeded those reported for standard chemotherapy regimens, and post-ASCT outcomes generally appeared excellent.
Frequency and Acceptability of Adverse Events After Anterior Cervical Discectomy and Fusion
Wilson, Jefferson R. , Schroeder, Gregory D. , Booth, Madison, Lucasti, Christopher , Fehlings, Michael G. , Nassr, Ahmad, Sciubba, Daniel M. , Ching, Alex, Smith, Justin S. , Shaffrey, Christopher I. , Singh, Kern , Darden, Bruce V., Daffner, Scott D. , Ludwig, Steven C. , Wang, Jeffrey , Lehman, Ronald A. , Hilibrand, Alan S. , Yoon, Tim , Grauer, Jonathan N. , Dailey, Andrew T. , Steinmetz, Michael P. , Ahmad, Nassr, Fehlings, Michael G , Radcliff, Kris E. , Vaccaro, Alexander R. , Arnold, Paul M. , Cheng, Ivan , Ghogawala, Zoher , Buchowski, Jacob M. , Brodke, Darrel Scott , Harrop, James Shields

Mayo Clinic

Clinical Spine Surgery: A Spine Publication | April 27, 2018 | Volume: 31 | Issue: 5 | Pages: E270-E277

10.1097/bsd.0000000000000645 | PMID 29708891 Get It

Purpose: Anterior cervical discectomy and fusion has a low but well-established profile of adverse events. The goal of this study was to gauge surgeon opinion regarding the frequency and acceptability of these events. Methods: A 2-page survey was distributed to attendees at the 2015 Cervical Spine Research Society (CSRS) meeting. Respondents were asked to categorize 18 anterior cervical discectomy and fusion–related adverse events as either: “common and acceptable,” “uncommon and acceptable,” “uncommon and sometimes acceptable,” or “uncommon and unacceptable.” Results were compiled to generate the relative frequency of these responses for each complication. Responses for each complication event were also compared between respondents based on practice location (US vs. non-US), primary specialty (orthopedics vs. neurosurgery) and years in practice. Results: Of 150 surveys distributed, 115 responses were received (76.7% response rate), with the majority of respondents found to be US-based (71.3%) orthopedic surgeons (82.6%). Wrong level surgery, esophageal injury, retained drain, and spinal cord injury were considered by most to be unacceptable and uncommon complications. Dysphagia and adjacent segment disease occurred most often, but were deemed acceptable complications. Although surgeon experience and primary specialty had little impact on responses, practice location was found to significantly influence responses for 12 of 18 complications, with non-US surgeons found to categorize events more toward the uncommon and unacceptable end of the spectrum as compared with US surgeons. Conclusions: These results serve to aid communication and transparency within the field of spine surgery, and will help to inform future quality improvement and best practice initiatives.
Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors
Phan, Jack , Pollard, Courtney , Brown, Paul D. , Guha‐Thakurta, Nandita , Garden, Adam S. , Fuller, Clifton D. , Frank, Steven J. , Gunn, G. Brandon , Morrison, William H. , Ho, Jennifer , Li, Jing , Ghia, Amol J. , Yang, James N., Luo, Dershan , Wang, He C., Su, Shirley Y. , Raza, Shaan M. , Gidley, Paul W. , Hanna, Ehab Y., Rosenthal, David I. , Hanna, Ehab Y. , DeMonte, Franco , Phan, Jack , Su, Shirley Y , Fuller, Clifton David

Mayo Clinic

Journal of Neurosurgery | April 27, 2018 | Volume: 130 | Issue: 3 | Pages: 812-821

10.3171/2017.11.jns172084 | PMID 29701557 Get It

OBJECTIVEThe objective of this study was to assess outcomes after Gamma Knife radiosurgery (GKRS) re-irradiation for palliation of patients with trigeminal pain secondary to recurrent malignant skull base tumors.METHODSFrom 2009 to 2016, 26 patients who had previously undergone radiation treatment to the head and neck received GKRS for palliation of trigeminal neuropathic pain secondary to recurrence of malignant skull base tumors. Twenty-two patients received single-fraction GKRS to a median dose of 17 Gy (range 15–20 Gy) prescribed to the 50% isodose line (range 43%–55%). Four patients received fractionated Gamma Knife Extend therapy to a median dose of 24 Gy in 3 fractions (range 21–27 Gy) prescribed to the 50% isodose line (range 45%–50%). Those with at least a 3-month follow-up were assessed for symptom palliation. Self-reported pain was evaluated by the numeric rating scale (NRS) and MD Anderson Symptom Inventory–Head and Neck (MDASI-HN) pain score. Frequency of as-needed (PRN) analgesic use and opioid requirement were also assessed. Baseline opioid dose was reported as a fentanyl-equivalent dose (FED) and PRN for breakthrough pain use as oral morphine-equivalent dose (OMED). The chi-square and Student t-tests were used to determine differences before and after GKRS.RESULTSSeven patients (29%) were excluded due to local disease progression. Two experienced progression at the first follow-up, and 5 had local recurrence from disease outside the GKRS volume. Nineteen patients were assessed for symptom palliation with a median follow-up duration of 10.4 months (range 3.0–34.4 months). At 3 months after GKRS, the NRS scores (n = 19) decreased from 4.65 ± 3.45 to 1.47 ± 2.11 (p < 0.001); MDASI-HN pain scores (n = 13) decreased from 5.02 ± 1.68 to 2.02 ± 1.54 (p < 0.01); scheduled FED (n = 19) decreased from 62.4 ± 102.1 to 27.9 ± 45.5 mcg/hr (p < 0.01); PRN OMED (n = 19) decreased from 43.9 ± 77.5 to 10.9 ± 20.8 mg/day (p = 0.02); and frequency of any PRN analgesic use (n = 19) decreased from 0.49 ± 0.55 to 1.33 ± 0.90 per day (p = 0.08). At 6 months after GKRS, 9 (56%) of 16 patients reported being pain free (NRS score 0), with 6 (67%) of the 9 being both pain free and not requiring analgesic medications. One patient treated early in our experience developed a temporary increase in trigeminal pain 3–4 days after GKRS requiring hospitalization. All subsequently treated patients were given a single dose of intravenous steroids immediately after GKRS followed by a 2–3-week oral steroid taper. No further cases of increased or new pain after treatment were observed after this intervention.CONCLUSIONSGKRS for palliation of trigeminal pain secondary to recurrent malignant skull base tumors demonstrated a significant decrease in patient-reported pain and opioid requirement. Additional patients and a longer follow-up duration are needed to assess durability of symptom relief and local control.
0469 The Impact of Varying Definitions of Hypopnea on the Diagnosis and Clinical Outcomes of Sleep Disordered Breathing: A Systematic Review and Meta-analysis
Wang, Z , Mansukhani, Meghna P. , Kolla, Bhanu Prakash , Morgenthaler, Timothy I.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A177-A177

10.1093/sleep/zsy061.468 Get It

1001 The Impact Of Alcohol On Sleep Disordered Breathing: A Systematic Review And Meta-analysis
Saeidifard, Farzane , Chakravorty, Subhajit , Wang, Zushen , Kolla, Bhanu Prakash , Foroughi, Mahnoosh , Mansukhani, Meghna P.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A370-A371

10.1093/sleep/zsy061.1000 Get It

Phenotypic Antimicrobial Susceptibility Testing with Deep Learning Video Microscopy
Yu, Hui , Jing, Wenwen , Iriya, Rafael , Yang, Yunze , Syal, Karan , Mo, Manni , Grys, Thomas E. , Tao, Nongjian , Wang, Shaopeng , Yu, Hui , Haydel, Shelley E. , Wang, Shaopeng , Grys, Thomas E , Jing, Wenwen

Mayo Clinic

Analytical Chemistry | April 20, 2018 | Volume: 90 | Issue: 10 | Pages: 6314-6322

10.1021/acs.analchem.8b01128 | PMID 29677440 Get It

Acute liver failure caused by hepatitis E virus genotype 3 and 4: A systematic review and pooled analysis
Haffar, Samir , Shalimar, S. , Kaur, Ravinder Jeet , Murad, M. Hassan , Bazerbachi, Fateh , Shalimar , Kaur, Ravinder J, Murad, Mohammad H, Bazerbachi, F , Haffar, S , Murad, M Hassan , Wang, Zhen , Prokop, Larry J.

Mayo Clinic

Liver International | April 20, 2018 | Volume: 38 | Issue: 11 | Pages: 1965-1973

10.1111/liv.13861 | PMID 29675889 Get It

AbstractBackground & AimsAcute liver failure caused by hepatitis E virus genotype 3 and 4 has been rarely described. Because of the presence of a short golden therapeutic window in patients with viral acute liver failure from other causes, it is possible that early recognition and treatment might reduce the morbidity and mortality. We performed a systematic review and pooled analysis of acute liver failure caused by hepatitis E virus genotype 3 and 4.MethodsTwo reviewers appraised studies after searching multiple databases on June 12th, 2017. Appropriate tests were used to compare hepatitis E virus genotype 3 vs 4, suspected vs confirmed genotypes, hepatitis E virus‐RNA positive vs negative, and to discern important mortality risk factors.ResultsWe identified 65 patients, with median age 58 years (range: 3‐79), and a male to female ratio of 1.2:1. The median bilirubin, ALT, AST and alkaline phosphatase (expressed by multiplication of the upper limit of normal) levels were 14.8, 45.3, 34.8 and 1.63 respectively. Antihepatitis E virus IgG, antihepatitis E virus IgM and hepatitis E virus‐RNA were positive in 84%, 91% and 86% of patients respectively. The median interval from symptoms onset to acute liver failure was 23 days, and 16 patients underwent liver transplantation. Final outcome was reported in 58 patients and mortality was 46%. Age was a predictor of poor prognosis in multivariate analysis. No important differences were found between patients infected with genotype 3 vs 4, patients with confirmed vs suspected genotypes, or patients with positive vs negative RNA.ConclusionAcute liver failure caused by hepatitis E virus genotype 3 and 4 is rare, similar between genotypes, occurs commonly in middle‐aged/elderly patients and has a very high mortality. Age is predictive of poor prognosis in multivariate analysis.
Single cardiac ventricular myosins are autonomous motors
Wang, Yihua , Yuan, Chen-Ching, Kaźmierczak, Katarzyna , Szczesna‐Cordary, Danuta , Burghardt, Thomas P. , Yuan, Chen‐Ching

Mayo Clinic

Open Biology | April 18, 2018 | Volume: 8 | Issue: 4 | Pages: 170240

10.1098/rsob.170240 | PMID 29669825 Get It

Myosin transduces ATP free energy into mechanical work in muscle. Cardiac muscle has dynamically wide-ranging power demands on the motor as the muscle changes modes in a heartbeat from relaxation, via auxotonic shortening, to isometric contraction. The cardiac power output modulation mechanism is explored in vitro by assessing single cardiac myosin step-size selection versus load. Transgenic mice express human ventricular essential light chain (ELC) in wild- type (WT), or hypertrophic cardiomyopathy-linked mutant forms, A57G or E143K, in a background of mouse α-cardiac myosin heavy chain. Ensemble motility and single myosin mechanical characteristics are consistent with an A57G that impairs ELC N-terminus actin binding and an E143K that impairs lever-arm stability, while both species down-shift average step-size with increasing load. Cardiac myosin in vivo down-shifts velocity/force ratio with increasing load by changed unitary step-size selections. Here, the loaded in vitro single myosin assay indicates quantitative complementarity with the in vivo mechanism. Both have two embedded regulatory transitions, one inhibiting ADP release and a second novel mechanism inhibiting actin detachment via strain on the actin-bound ELC N-terminus. Competing regulators filter unitary step-size selection to control force-velocity modulation without myosin integration into muscle. Cardiac myosin is muscle in a molecule.
Endosomal receptor trafficking: Retromer and beyond
Wang, Jing , Fedoseienko, Alina , Chen, Baoyu , Billadeau, Daniel D. , Billadeau, Daniel D , Burstein, Ezra , Jia, Da

Mayo Clinic

Traffic | April 18, 2018 | Volume: 19 | Issue: 8 | Pages: 578-590

10.1111/tra.12574 | PMID 29667289 Get It

The tubular endolysosomal network is a quality control system that ensures the proper delivery of internalized receptors to specific subcellular destinations in order to maintain cellular homeostasis. Although retromer was originally described in yeast as a regulator of endosome‐to‐Golgi receptor recycling, mammalian retromer has emerged as a central player in endosome‐to‐plasma membrane recycling of a variety of receptors. Over the past decade, information regarding the mechanism by which retromer facilitates receptor trafficking has emerged, as has the identification of numerous retromer‐associated molecules including the WASH complex, sorting nexins (SNXs) and TBC1d5. Moreover, the recent demonstration that several SNXs can directly interact with retromer cargo to facilitate endosome‐to‐Golgi retrieval has provided new insight into how these receptors are trafficked in cells. The mechanism by which SNX17 cargoes are recycled out of the endosomal system was demonstrated to involve a retromer‐like complex termed the retriever, which is recruited to WASH positive endosomes through an interaction with the COMMD/CCDC22/CCDC93 (CCC) complex. Lastly, the mechanisms by which bacterial and viral pathogens highjack this complex sorting machinery in order to escape the endolysosomal system or remain hidden within the cells are beginning to emerge. In this review, we will highlight recent studies that have begun to unravel the intricacies by which the retromer and associated molecules contribute to receptor trafficking and how deregulation at this sorting domain can contribute to disease or facilitate pathogen infection.
The effect of publication bias magnitude and direction on the certainty in evidence
Murad, M. Hassan , Lin, Lifeng , Murad, M Hassan , Lin, Lifeng , Chu, Haitao , Wang, Zhen

Mayo Clinic

BMJ Evidence-Based Medicine | April 12, 2018 | Volume: 23 | Issue: 3 | Pages: 84-86

10.1136/bmjebm-2018-110891 | PMID 29650725 Get It

Publication bias occurs when studies with statistically significant results have increased likelihood of being published. Publication bias is commonly associated with inflated treatment effect which lowers the certainty of decision makers about the evidence. In this guide we propose that systematic reviewers and decision makers consider the direction and magnitude of publication bias, as opposed to just the binary determination of the presence of this bias, before lowering their certainty in the evidence. Direction of bias may not always exaggerate the treatment effect. The presence of bias with a trivial magnitude may not affect the decision at hand. Various statistical approaches are available to determine the direction and magnitude of publication bias.